Medicinova, Inc.

MNOV

...

MNOV: MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.

Show MNOV Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of MNOV by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

No Whale Activity for this ticker

Institutional Holdings Dashboard

Insider Trading

Quarterly net insider trading by MNOV's directors and management

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

No new patents for this ticker

U.S. Patents Dashboard

Government Contracts

Federal grants, loans, and purchases

$699,000 2021-03-04 00:00:00 Agency: DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS)

Twitter

Followers on MNOV's company Twitter account

WallStreetBets

Number of mentions of MNOV in WallStreetBets Daily Discussion

MNOV News

Recent insights relating to MNOV

CNBC Recommendations

Recent picks made for MNOV stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in MNOV

Corporate Flights

Flights by private jets registered to MNOV